Cargando…
Longevity-Associated Variant of BPIFB4 Confers Neuroprotection in the STHdh Cell Model of Huntington Disease
Huntington’s disease (HD) is caused by the production of mutant Huntingtin (mHTT), characterized by long polyglutamine repeats with toxic effects. There are currently no clinically validated therapeutic agents that slow or halt HD progression, resulting in a significant clinical unmet need. The stri...
Autores principales: | Cattaneo, Monica, Maciag, Anna, Milella, Maria Serena, Ciaglia, Elena, Bruno, Antonino, Puca, Annibale Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737551/ https://www.ncbi.nlm.nih.gov/pubmed/36499641 http://dx.doi.org/10.3390/ijms232315313 |
Ejemplares similares
-
A Model of Evolutionary Selection: The Cardiovascular Protective Function of the Longevity Associated Variant of BPIFB4
por: Villa, Francesco, et al.
Publicado: (2018) -
The longevity-associated variant of BPIFB4 improves a CXCR4-mediated striatum–microglia crosstalk preventing disease progression in a mouse model of Huntington’s disease
por: Di Pardo, Alba, et al.
Publicado: (2020) -
New Insights for BPIFB4 in Cardiovascular Therapy
por: Dossena, Marta, et al.
Publicado: (2020) -
The Role of BPIFB4 in Immune System and Cardiovascular Disease: The Lesson from Centenarians
por: Montella, Francesco, et al.
Publicado: (2021) -
Transfer of the longevity-associated variant of BPIFB4 gene rejuvenates immune system and vasculature by a reduction of CD38(+) macrophages and NAD(+) decline
por: Ciaglia, Elena, et al.
Publicado: (2022)